Northwest Biotherapeutics (NWBO) Interest & Investment Income (2010)
Northwest Biotherapeutics (NWBO) posted quarterly Interest & Investment Income of $489000.0 for Q4 2010.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Interest & Investment Income (2010) Analysis & Trends
Northwest Biotherapeutics' Interest & Investment Income history runs 1 years deep, the most recent figure standing at $489000.0 for Q4 2010.
- In Q4 2010, Interest & Investment Income changed N/A year-over-year to $489000.0; the TTM figure through Sep 2011 stood at $489000.0 (changed N/A YoY), while the FY2010 annual figure was $489000.0, changed N/A from the prior year.
- Interest & Investment Income for Q4 2010 stood at $489000.0.
- The five-year high for Interest & Investment Income was $489000.0 in Q4 2010, with the low at $489000.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Northwest Biotherapeutics | 278.23 Mn | 277.63 Mn | - | - |